Patents by Inventor Donald B. Carter

Donald B. Carter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • High-level production of amyloid-beta peptides from IMR-32 cells
    Publication number: 20030199003
    Abstract: Methods for producing peptides resulting from the proteolytic processing of amyloid precursor protein (APP). The methods involve high-density plating of IMR-32 cells. IMR-32 cells produced by the methods of the present invention are useful for screening for modulators of peptides resulting from proteolytic processing of APP, e.g., A&bgr; and sAPP&agr;.
    Type: Application
    Filed: February 20, 2003
    Publication date: October 23, 2003
    Inventors: Nancy C. Stratman, Donald B. Carter
  • Pump-in-pipe
    Patent number: 6050789
    Abstract: Adapter for installing deep-well submersible pump with a motor in casings with inflatable seal means comprising an annular inflatable tubular bladder with pipe flow-through means, communicating with the pump; adapter and pump suspended by cable means and air pressure line means, communicating with bladder so that it can contact the cylindrical casing; and with electric cable power means communicating with pump motor and with guide wheels to negotiate curves and reduce friction on sloping casings.
    Type: Grant
    Filed: November 20, 1997
    Date of Patent: April 18, 2000
    Inventors: James H. Melby, Donald B. Carter
  • Use of imidazo?1,5-a!quinolones as neuroprotective agents
    Patent number: 5935970
    Abstract: The imidazo?1,5-a!quinolines (I) are useful in treating neurological diseases/conditions or chronic neurodegenerative diseases/conditions.
    Type: Grant
    Filed: June 3, 1996
    Date of Patent: August 10, 1999
    Assignee: Pharmacia & Upjohn Company
    Inventor: Donald B. Carter
  • Transformed cells comprising GABA.sub.A receptors
    Patent number: 5166066
    Abstract: A stable transformed HEK 293 cell comprising a functional GABA.sub.A receptor that comprises a GABA.sub.A receptor .alpha. subunit, a GABA.sub.A receptor .beta. subunit and a GABA.sub.A receptor .gamma. subunit is disclosed.
    Type: Grant
    Filed: July 11, 1991
    Date of Patent: November 24, 1992
    Assignee: The Upjohn Company
    Inventor: Donald B. Carter
  • Monoclonal antibody to prostate secretory protein
    Patent number: 4863851
    Abstract: Provided are hybridomas for producing monoclonal antibodies against human prostate secretory protein (PSP15), anti-PSP15 monoclonal antibodies, fragments and derivatives thereof, and methods for their use. The antibodies are monospecific, bind to protein A and are of the IgM class of immunoglobulins. The monoclonal antibodies are useful as basic diagnostics for detecting human prostate cancer cells.
    Type: Grant
    Filed: October 20, 1986
    Date of Patent: September 5, 1989
    Assignee: The Upjohn Company
    Inventors: Robert N. McEwan, Donald B. Carter